Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
The purpose of this notice of funding opportunity (NOFO) is to support research and/or preclinical development of highly efficacious vaccines against malaria - one of the deadliest mosquito-borne diseases - by capitalizing on recent technological innovations, particularly in structure-based immunogen design, improved formulations, and combination vaccines. The goal is to achieve long-lasting, highly effective protection that can save lives, strengthen public health security in the United States, and serve as a model for, or are potentially effective against, other mosquito-borne diseases.
Historique des changements
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · f4c26c45c868
- 22 Oct 2026 · 72a432d316c2
- 21 Oct 2026 · 4a02ecc55d79
- 20 Oct 2026 · 71f86d540332
- 19 Oct 2026 · cb8c8b52849a
- 18 Oct 2026 · 66228cc15c73
- 17 Oct 2026 · bb4a538e0962
- 16 Oct 2026 · afc003eeef63
- 15 Oct 2026 · d1ca3d4938ee
- 14 Oct 2026 · eb7045b8813d
- 13 Oct 2026 · d2c3149d9e86
- 12 Oct 2026 · 4c7e659cde32
- 11 Oct 2026 · 0affe3f875e0
- 10 Oct 2026 · 97a11a4447e9
- 09 Oct 2026 · c41013872f85
- 08 Oct 2026 · aa66315b54a2
- 07 Oct 2026 · 2092ef983369
- 06 Oct 2026 · 34a80dfa512e
- 05 Oct 2026 · 02e761ef9f59
- 04 Oct 2026 · 0d7b3fd20766